Has Ibrahim Sultan, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,917,711 in general payments to Ibrahim Sultan, MD across 734 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ibrahim Sultan, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ibrahim Sultan, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ibrahim Sultan, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Pgh., PANPI 1477726115

Payments from drug & device makers

$2,917,711in general payments, 2019–2025

Across 734 payments — averaging $3975.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Atricure, Inc.$975K
Abbott$898K
Medtronic$588K
Bolton Medical Inc$218K
Edwards Lifesciences$108K
Artivion, Inc.$58K
plus $73K from 10 others

$6,624in research payments, 2019–2025

Across 7 payments — averaging $946.21 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$4K
Cook Research Incorporated$2K
Artivion, Inc.$750

What the payments were for

Consulting fees$62,80852%
Speaking & faculty fees$18,31515%
Travel & lodging$20,45517%
Food & beverage$19,43316%
Other$2820%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Atricure, Inc.	48	$974,540
Abbott	314	$898,048
Medtronic(2 entities)	217	$587,519
Bolton Medical Inc	45	$218,162
Edwards Lifesciences	50	$108,200
Artivion, Inc.	23	$57,793
Boston Scientific	15	$34,500
W. L. Gore & Associates, Inc.	14	$22,400
Z-medica, LLC	1	$11,500
Integer Holdings Corporation	1	$4,561
Abiomed	1	$166
Baxter Healthcare	1	$123
LSI Solutions Inc	1	$83
Cook Medical LLC	1	$69
Stryker	1	$24
Intuitive Surgical	1	$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SYNERGY ABLATION SYSTEM$29,377
NAVITOR$16,050
Valiant Captivia$13,651
RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM$9,500
PORTICO$5,609
E-vita OPEN NEO$5,347
Abbott (Circulo) TAVR$4,561
Epic$3,147
Avalus$2,300
Grafts$1,932
ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2)$1,739
ENDURANT IIS$1,500
Product in Development$1,389
EPI-SENSE GUIDED COAGULATION SYS$1,230
TREO ABDOMINAL STENT-GRAFT SYSTEM$877
Cardioblate$848
ATRICLIP LAA EXCLUSION SYSTEM$708
MitraClip$644
VersaCross Access Solution$602
EVOQUE$595

How this compares

$2,917,711 in reported general payments places this provider in the 95th percentile of 314 thoracic surgery (cardiothoracic vascular surgery) providers in Pennsylvania.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$164,681

Medicare patients

Services billed

188

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	22	$16,841
Enoxaparin Sodium	12	$1,397
ClopidogrelClopidogrel Bisulfate	32	$470
Losartan Potassium	28	$410
Atorvastatin Calcium	11	$314
Mupirocin	53	$306
Carvedilol	23	$297
Metoprolol Tartrate	23	$280
Prednisone	20	$16
Furosemide	12	$13

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Pgh.

Joseph BavariaAllentown$6.6M
Mubashir MumtazHarrisburg$5M
Basel RamlawiWynnewood$4.4M
Nimesh DesaiPhiladelphia$1.6M
Benny WekslerPittsburgh$1.5M
Stephen BaileyPittsburgh$1.3M
Scott GoldmanWynnewood$1.1M
Wilson SzetoPhiladelphia$1.1M
Patrick RossWynnewood$956K
Walter McGregorPittsburgh$715K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →